Mortalin antibody-conjugated quantum dot transfer from human mesenchymal stromal cells to breast cancer cells requires cell-cell interaction

Experimental Cell Research

Volumn 319, Issue 18, 2013, Pages 2770-2780

  Pietilä, Mika ^a   Lehenkari, Petri ^b   Kuvaja, Paula ^b,c   Kaakinen, Mika ^b   Kaul, Sunil C ^a   Wadhwa, Renu ^a   Uemura, Toshimasa ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b UNIVERSITY OF OULU   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Anti mortalin antibody; Breast cancer cells; Co culture; Human mesenchymal stromal cells; I QDs

Indexed keywords

ACTIN; ANTIBODY; MORTALIN; MORTALIN ANTIBODY; PROTEIN; QUANTUM DOT; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CELL COMMUNICATION; CELL INTERACTION; CELL LABELING; ELECTRON MICROSCOPE; FLUORESCENCE MICROSCOPE; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STROMA CELL; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84886239689     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.07.023     Document Type: Article

References (50)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics, CA cancer. J. Clin. 2011, 61:69-90.
2. Bissell M.J., Radisky D. Putting tumours in context. Nat. Rev. Cancer 2001, 1:46-54.
3. Arendt L.M., Rudnick J.A., Keller P.J., Kuperwasser C. Stroma in breast development and disease. Semin. Cell Dev. Biol. 2010, 21:11-18.
4. Balliet R.M., Capparelli C., Guido C., et al. Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: understanding the aging and cancer connection. Cell Cycle 2011, 10:4065-4073.
5. Gao M.Q., Kim B.G., Kang S., Choi Y.P., Park H., Kang K.S., Cho N.H. Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial-mesenchymal transition-like state in breast cancer cells in vitro. J. Cell. Sci. 2010, 123:3507-3514.
6. Pavlides S., Vera I., Gandara R., et al. Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. Antioxid Redox Signal 2012, 16:1264-1284.
7. Tyan S.W., Hsu C.H., Peng K.L., Chen C.C., Kuo W.H., Lee E.Y., Shew J.Y., Chang K.J., Juan L.J., Lee W.H. Breast cancer cells induce stromal fibroblasts to secrete ADAMTS1 for cancer invasion through an epigenetic change. PLoS One 2012, 7:e35128.
8. De Luca A., Lamura L., Gallo M., Maffia V., Normanno N. Mesenchymal stem cells-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration. J. Cell. Biochem. 2012.
9. Devarajan E., Song Y.H., Krishnappa S., Alt E. Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells. Int. J. Cancer 2012, 131:1023-1031.
10. Korkaya H., Liu S., Wicha M.S. Breast cancer stem cells, cytokine networks, and the tumor microenvironment. J. Clin. Invest. 2011, 121:3804-3809.
11. Xu Q., Wang L., Li H., Han Q., Li J., Qu X., Huang S., Zhao R.C. Mesenchymal stem cells play a potential role in regulating the establishment and maintenance of epithelial-mesenchymal transition in MCF7 human breast cancer cells by paracrine and induced autocrine TGF-beta. Int. J. Oncol. 2012, 41:959-968.
12. Li H.J., Reinhardt F., Herschman H.R., Weinberg R.A. Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. Cancer Discovery 2012, 2:840-855.
13. Martin F.T., Dwyer R.M., Kelly J., Khan S., Murphy J.M., Curran C., Miller N., Hennessy E., Dockery P., Barry F.P., T.O'brien, Kerin M.J. Potential role of mesenchymal stem cells (MSCs) in the breast tumor microenvironment: stimulation of epithelial to mesenchymal transition (EMT). Breast Cancer Res. Treat. 2010, 124:317-326.
14. Rappa G., Mercapide J., Lorico A. Spontaneous formation of tumorigenic hybrids between breast cancer and multipotent stromal cells is a source of tumor heterogeneity. Am. J. Pathol. 2012, 180:2504-2515.
15. Lu X., Kang Y. Efficient acquisition of dual metastasis organotropism to bone and lung through stable spontaneous fusion between MDA-MB-231 variants. Proc. Natl. Acad. Sci. USA 2009, 106:9385-9390.
16. Ding J., Jin W., Chen C., Shao Z., Wu J. Tumor associated macrophage x cancer cell hybrids may acquire cancer stem cell properties in breast cancer. PLoS One 2012, 7:e41942.
17. Castellone M.D., Laatikainen L.E., Laurila J.P., Langella A., Hematti P., Soricelli A, Salvatore M., Laukkanen M.O. Mesenchymal stromal cell atrophy in co-cultures increases aggressiveness of transformed cells 2013, ([Epub ahead of print]). 10.1002/stem.1361.
18. Reagan M.R., Kaplan D.L. Concise review: mesenchymal stem cell tumor-homing: detection methods in disease model systems. Stem Cells 2011, 29:920-927.
19. Muehlberg F.L., Song Y.H., Krohn A., et al. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 2009, 30:589-597.
20. Goldstein R.H., Reagan M.R., Anderson K., Kaplan D.L., Rosenblatt M. Human bone marrow-derived MSCs can home to orthotopic breast cancer tumors and promote bone metastasis. Cancer Res. 2010, 70:10044-10050.
21. Karnoub A.E., Dash A.B., Vo A.P., Sullivan A., Brooks M.W., Bell G.W., Richardson A.L., Polyak K., Tubo R., Weinberg R.A. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007, 449:557-563.
22. Sanchez C.G., Penfornis P., Oskowitz A.Z., Boonjindasup A.G., Cai D.Z., Dhule S.S., Rowan B.G., Kelekar A., Krause D.S., Pochampally R.R. Activation of autophagy in mesenchymal stem cells provides tumor stromal support. Carcinogenesis 2011, 32:964-972.
23. Ma Y., Hao X., Zhang S., Zhang J. The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells. Breast Cancer Res. Treat. 2012, 133:473-485.
24. Qiao L., Xu Z.L., Zhao T.J., Ye L.H., Zhang X.D. Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of wnt signalling. Cancer Lett. 2008, 269:67-77.
25. Martinez-Outschoorn U.E., Lin Z., Trimmer C., Flomenberg N., Wang C., Pavlides S., Pestell R.G., Howell A., Sotgia F., Lisanti M.P. Cancer cells metabolically fertilize the tumor microenvironment with hydrogen peroxide, driving the warburg effect: Implications for PET imaging of human tumors. Cell Cycle 2011, 10:2504-2520.
26. Capparelli C., Guido C., Whitaker-Menezes D., et al. Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production. Cell Cycle 2012, 11:2285-2302.
27. Wadhwa R., Kaul S.C., Ikawa Y., Sugimoto Y. Identification of a novel member of mouse hsp70 family its association with cellular mortal phenotype. J. Biol. Chem. 1993, 268:6615-6621.
28. Kaul S.C., Wadhwa R., Komatsu Y., Sugimoto Y., Mitsui Y. On the cytosolic and perinuclear mortalin: an insight by heat shock. Biochem. Biophys. Commun. 1993, 193:348-355.
29. Wadhwa R., Takano S., Kaul K., Deocaris C.C., Pereira-Smith O.M., Reddel R.R., Kaul S.C. Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis. Int. J. Cancer 2006, 118:2973-2980.
30. Ran Q., Wadhwa R., Kawai R., Kaul S.C., Sifers R.N., Bick R.J., Smith J.R., Pereire-Smith O.M. Extramitochondrial localization of mortalin/mthsp70/PBP74/GRP75. Biochem. Biophys. Res. Commun. 2000, 275:174-179.
31. Lu W.J., Lee N.P., Kaul S.C., Lan F., Poon R.T., Wadhwa R., Luk J.M. Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy. Cell Death Differ. 2011, 18:1046-1056.
32. Ji X., Luk J.M., Lee N.P., Peng J., Leng X., Guan X.Y., Lau G.K., Beretta L., Fan S.T. Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol. Cell Proteomics 2008, 7:315-325.
33. Rozenberg P., Kocsis J., Saar M., Prohászka Z., Füst G., Fishelson Z. Elevated levels of mitochondrial mortalin and cytosolic HSP70 in blood as risk factors in colorectal cancer patients, Int. J. Cancer 2013, ([Epub ahead of print]). 10.1002/ijc.28029.
34. Ohyabu Y., Kaul Z., Yoshioka T., Inoue K., Sakai S., Mishima H., Uemura T., Kaul S.C., Wadhwa R. Stable and nondisruptive in vitro/in vivo labeling of mesenchymal stem cells by internalizing quantum dots. Hum. Gene Ther. 2009, 20:217-224.
35. Shiota M., Ikeda Y., Kaul Z., Itadani J., Kaul S.C., Wadhwa R. Internalizing antibody-based targeted gene delivery for human cancer cells, Hum. Gene Ther. 2007, 18:1153-1160.
36. Leskela H.V., Risteli J., Niskanen S., Koivunen J., Ivaska KK., Lehenkari P. Osteoblast recruitment from stem cells does not decrease by age at late adulthood. Biochem. Biophys. Res. Commun. 2003, 311:1008-1013.
37. Paapponen H., Kaisto T., Leinonen S., Kaakinen M., Metsikkö K. Evidence for gamma-actin as a Z disc component in skeletal myofibers. Exp. Cell Res. 2009, 315:218-225.
38. Chu P.P., Bari S., Fan X., Gay F.P., Ang J.M., Chiu G.N., Lim S.K., Hwang W.Y. Intercellular cytosolic transfer correlates with mesenchymal stromal cell rescue of umbilical cord blood cell viability during ex vivo expansion. Cytotherapy 2012, 14:1064-1079.
39. Cho J.A., Park H., Lim E.H., Lee K.W. Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells. Int. J. Oncol. 2012, 40:130-138.
40. Vallabhaneni K.C., Haller H., Dumler I. Vascular smooth muscle cells initiate proliferation of mesenchymal stem cells by mitochondrial transfer via tunneling nanotubes. Stem Cells Dev. 2012, 21:3104-3113.
41. Acquistapace A., Bru T., Lesault P.F., Fiqeac F., Coudert A.E., le Coz O., Christov C, Baudin X., Auber F., Yiou R., Dubois-Randé J.L., Rodriquez A.M. Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer 2011, 29. (812-2).
42. Luca V., Zhang L., Viloria-Petit A.M., Oqunjimi A.A., Inanlou M.R., Chiu E., Buchanan M., Hosein A.N., Basik M., Wrana J.L. Exosomes mediate stromal mobilization of autocrine Wnt-PCP Signaling in breast cancer cell migration. Cell 2012, 151:1542-1556.
43. Collino F., Deregibus M.C., Bruno S., Sterpone L., Aghemo G., Viltono L., Tetta C., Camussi G. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected patter of miRNAs. PLoS One 2010, 5:e11803.
44. Kim H.S., Choi D.Y., Yun S.J., Choi S.M., Kang J.W., Jung J.W., Hwang D., Kim K.P., Kim D.W. Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J. Proteome Res. 2012, 11:839-849.
45. Lou E., Fujisawa S., Morozov A., Barlas A., Romin Y., Dogan Y., Gholami S., Moreira A.L., Manova-Todorova K., Moore M.A.S. Tunneling nanotubes provide a unique conduit for intercellular transfer of cellular contents in human malignant pleural mesothelioma. PLoS One 2012, 7:e33093.
46. Yoon B.S., Yoo S.J., Lee J.E., You S., Lee H.T., Yoon H.S. Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-azacytidine treatment. Differentiation 2006, 74:149-159.
47. Chen M., Lin Y.Q., Xie S.L., Wu H.F., Wang J.F. Enrichment of cardiac differentiation of mouse embryonic stem cells by optimizing the hanging drop method. Biotechnol. Lett. 2011, 33:853-858.
48. Kelm J.M., Timmins N.E., Brown C.J., Fussenegger M., Nielsen L.K. Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol. Bioeng. 2003, 83:173-180.
49. Morrison B.J., Hastie M.L., Grewal Y.S., Bruce Z.C., Schmidt C., Reynolds B.A., Gorman J.J., Lopez J.A. Proteomic comparison of mcf-7 tumorsphere and monolayer cultures. PLoS One 2012, 7:e52692.
50. Neiva K.G., Zhang Z., Miyazawa M., Warner K.A., Karl E., Nör J.E. Cross talk initiated by endothelial cells enhances migration and inhibits anoikis of squamous cell carcinoma cells through STAT3/Akt/ERK signaling. Neoplasia 2009, 11:583-593.